Pramlintide

DRUG15 trials

Sponsors

Baylor College of Medicine, Diabetes Care Center, Ludwig-Maximilians - University of Munich, University of Texas Southwestern Medical Center, University of Colorado, Denver

Conditions

Bone Diseases, MetabolicCutaneous Squamous Cell CarcinomaDiabetesDiabetes MellitusDiabetes Mellitus, Type 1Evidence of Previous Gastric SurgeryHypoglycemiaSchizoaffective Disorder

Early Phase 1

Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study

WithdrawnNCT04252612

H. Lee Moffitt Cancer Center and Research InstituteCutaneous Squamous Cell Carcinoma

Start: 2020-01-30End: 2023-06-26Updated: 2023-06-28

Phase 1

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

WithdrawnNCT01165944

University of Colorado, DenverDiabetes Mellitus

Start: 2009-08-31End: 2011-08-31Updated: 2018-07-26

Phase 2

A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes

RecruitingNCT06046417

McGill University Health Centre/Research Institute of the McGill University Health CentreDiabetes Mellitus, Type 1, type1diabetes

Start: 2023-11-30End: 2025-06-30Target: 30Updated: 2024-04-18

Phase 3

The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes

CompletedNCT00206297

Baylor College of MedicineType 1 Diabetes

Start: 2003-10-31End: 2006-02-28Target: 20Updated: 2016-07-14

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

Cheryl Rosenfeld, DOType 2 Diabetes Mellitus

Start: 2010-05-31End: 2012-04-30Target: 40Updated: 2011-10-14

Phase 4

Continuous Subcutaneous Infusion of Pramlintide and Insulin

CompletedNCT00291772

Baylor College of MedicineType 1 Diabetes

Start: 2006-01-31End: 2007-11-30Updated: 2016-07-14

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

WithdrawnNCT00505882

University of Texas Southwestern Medical CenterType 1 Diabetes

Start: 2007-07-31End: 2008-12-31Updated: 2019-01-08

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

CompletedNCT00690235

University of Texas Southwestern Medical CenterDiabetes, Schizoaffective Disorder, Schizophrenia +1

Start: 2007-11-30End: 2011-08-31Updated: 2018-11-16

Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

CompletedNCT01269047

Albert Einstein College of MedicineType 1 Diabetes

Start: 2009-08-31End: 2016-12-31Updated: 2018-04-12

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

CompletedNCT01841359

Joslin Diabetes CenterEvidence of Previous Gastric Surgery, Hypoglycemia

Start: 2010-02-02End: 2022-02-08Updated: 2023-06-29

Unknown Phase

The Effect of Pramlintide on Meal Time Insulin Bolus

CompletedNCT00460304

Diabetes Care CenterType 1 Diabetes

Start: 2007-09-30End: 2008-11-30Target: 12Updated: 2009-04-03

Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide

CompletedNCT00489645

Ludwig-Maximilians - University of MunichType 1 Diabetes

Start: 2005-01-31End: 2007-04-30Updated: 2008-01-16

Pramlintide in Adolescents With Type 1 Diabetes

CompletedNCT00842075

University of Colorado, DenverType 1 Diabetes

Start: 2006-12-31End: 2009-12-31Updated: 2015-06-23

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

CompletedNCT05199714

McGill University Health Centre/Research Institute of the McGill University Health CentreType 1 Diabetes

Start: 2022-02-21End: 2023-03-25Updated: 2023-10-25

The Role of Amylin in Bone Metabolism

RecruitingNCT06186063

Filip Krag KnopBone Diseases, Metabolic, Type 1 Diabetes

Start: 2024-02-12End: 2024-08-01Target: 20Updated: 2024-02-21

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01